Prevalence of spina bifida at birth--United States, 1983-1990: a comparison of two surveillance systems

J M Lary1, L D Edmonds

  • 1Division of Birth Defects and Developmental Disabilities National Center for Environmental Health.

Insights

Multistate surveillance of spina bifida from 1983-1990 revealed declining birth prevalence rates. These findings support monitoring neural tube defects (NTDs) to assess public health interventions like folic acid supplementation.

Area of Science:

  • Epidemiology
  • Public Health Surveillance
  • Birth Defects Research

Background:

  • Spina bifida, a neural tube defect (NTD), is a major cause of developmental disabilities in the US.
  • Folic acid consumption before and during early pregnancy significantly reduces the risk of NTDs.
  • Public health initiatives aim to increase folic acid intake among women of childbearing age to prevent NTDs.

Purpose of the Study:

  • To gather multistate, population-based data on the birth prevalence and epidemiology of spina bifida.
  • To evaluate the utility of combining state surveillance data for monitoring national NTD trends.
  • To assess the impact of public health programs on NTD prevalence.

Main Methods:

  • Analysis of population-based data on live-born and stillborn infants with spina bifida from 16 state birth defect surveillance programs (1983-1990).
  • Comparison with data from the CDC's Birth Defects Monitoring Program (BDMP).
  • Inclusion of data from hospital-based surveillance systems with varying methodologies and case ascertainment.

Main Results:

  • The overall birth prevalence rate for spina bifida was 4.6 per 10,000 births (state data) and 4.4 per 10,000 (BDMP data) from 1983-1990.
  • Significant state-specific and racial/ethnic variations in prevalence were observed, with highest rates in Hispanics.
  • A decline in spina bifida rates was noted during 1983-1990, potentially influenced by prenatal diagnosis and environmental factors.

Conclusions:

  • Both state-based and BDMP surveillance systems provide reliable data for monitoring national trends in spina bifida prevalence.
  • Continued surveillance is crucial for tracking NTDs and evaluating the effectiveness of folic acid fortification programs.
  • Findings support the use of aggregated state data to monitor changes in NTDs following public health interventions.
Abstract